Skip to main content
    N

    Nutriband Inc (NTRB)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $5.59
    -0.22 (-3.79%)

    Market Cap: $70.63M

    Last updated: Nov 17, 2026 at 4:15 PM ET

    Nutriband Inc (NTRB) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Nutriband (NTRB) has a market cap of $70.63M and an enterprise value of $67.36M. It kept -430.43% of revenue as net income over the last 12 months. Its share count is up 8.36% from a year earlier.

    Total Valuation

    Enterprise value is 4.63% below the market cap, as cash exceeds debt.

    Market Cap$70.63M
    Enterprise Value$67.36M
    Latest price (Nov 17, 2026)$5.59

    Key Dates

    The next earnings report is set for Dec 9, 2026.

    Next Earnings DateDec 9, 2026
    Last Earnings DateSep 4, 2026
    Fiscal Year EndJanuary

    Share Statistics

    The share count held steady in the quarter ended Jul 31, 2026 and grew 4.83% a year over 2 years.

    Shares Outstanding12.16M
    Shares Change (YoY)+8.36%
    Shares Change (QoQ)0.00%
    Share Count Growth (2Y CAGR)+4.83%

    Valuation Ratios

    Sales and book value multiples are 42.0x and 12.8x. Its year-end P/S ranged from 9.6x to 124.0x from 2020 to 2025.

    P/S Ratio42.0x
    P/B Ratio12.8x
    P/TBV Ratio19.8x

    Valuation history and multiples

    Price Statistics

    The stock is up 1.64% over 52 weeks and trades 15.17% below its 50-day average.

    Beta (1Y)1.09
    52-Week Change+1.64%
    1-Month Change-6.83%
    3-Month Change+57.46%
    6-Month Change+62.03%
    5-Year Change+0.64%
    Total Return (1Y)+1.64%
    Total Return (3Y CAGR)+46.10%
    Total Return (5Y CAGR)+6.46%
    Return vs SPY (1Y)-2.17%
    Max Drawdown (1Y)-49.55%
    Max Drawdown (3Y)-67.23%
    Sharpe Ratio (1Y)0.12
    Correlation with SPY (1Y)0.19
    50-Day Average$6.59
    200-Day Average$4.44
    52-Week Range$2.80 to $9.19
    RSI (14 Days)42.6
    Average Volume (20 Days)21.34K

    The 5-year change compares month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 4.21x current liabilities, and total debt is 0.03x shareholder equity.

    Current Ratio4.21x
    Quick Ratio4.02x
    Debt / Equity0.03x
    Interest Coverage-338.51x

    Returns and Efficiency

    Return on invested capital is -101.29% over the last 12 months, against a 5-year average of -71.56%.

    Return on Equity (ROE)-130.67%
    Return on Assets (ROA)-110.64%
    Return on Invested Capital (ROIC)-101.29%
    ROE (5Y Average)-95.17%
    ROA (5Y Average)-83.64%
    ROIC (5Y Average)-71.56%
    Asset Turnover0.20x
    Inventory Turnover7.40x
    Receivables Turnover123.37x
    Cash Conversion Cycle-164 days

    Scores

    NTRB has an Altman Z-Score of 28.54, in the safe zone above 2.99, and a Piotroski F-Score of 4 of 9, in the average band of 3 to 7.

    Altman Z-Score28.54
    Altman Z ZoneSafe
    Piotroski F-Score4 of 9
    Piotroski StrengthAverage

    Income Statement

    Revenue of $1.62M over the last 12 months is down 37.25% from the 12 months before.

    Revenue$1.62M
    Revenue Growth (YoY)-37.25%
    Gross Profit$536.12K
    Operating Income-$7.05M
    Pretax Income-$6.96M
    Net Income-$6.96M
    EBITDA-$6.88M
    Reported EPS (TTM)-$0.51

    Trailing 12 months through Jul 31, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 84.74% of the $6.29M in total assets.

    Cash and Equivalents$3.42M
    Total Debt$153.54K
    Net Cash$3.27M
    Net Cash Per Share$0.27
    Working Capital$2.91M
    Shareholder Equity$5.33M
    Book Value Per Share$0.44
    Tangible Book Value$3.44M
    Tangible Book Per Share$0.28
    Total Assets$6.29M
    Total Liabilities$964.36K

    Balance sheet as of Jul 31, 2026.

    Full balance sheet

    Cash Flow

    Operating Cash Flow-$3.63M
    FCF Per Share-$0.30
    Depreciation and Amortization$146.44K

    Trailing 12 months through Jul 31, 2026.

    Full cash flow statement

    Margins

    The operating margin is -435.58%.

    Gross Margin33.14%
    Operating Margin-435.58%
    Pretax Margin-430.43%
    Net Margin-430.43%
    EBITDA Margin-425.45%
    Gross Margin (5Y Average)35.09%

    Growth

    Revenue fell 0.69% a year over 3 years.

    Revenue Growth (3Y CAGR)-0.69%
    Revenue Growth (5Y CAGR)+16.63%

    Revenue and profit by year

    Dividends and Yields

    NTRB does not pay a dividend.

    Buyback Yield0.00%
    Shareholder Yield0.00%

    Stock Splits

    The last split was a 1-for-4 reverse split on Jul 24, 2019.

    Last Split DateJul 24, 2019
    Split TypeReverse split
    Split Ratio1:4

    Peer Position

    Against 6 similar companies, NTRB has the 2nd highest P/S.

    P/S Ratio42.0x vs 14.7x median
    ROIC-101.29% vs -106.71% median
    Revenue Growth (Trailing 4 Quarters, YoY)-37.25% vs -15.25% median

    Competitors compared

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    GNG Valuation

    GNG viewOvervalued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About NTRB

    What is NTRB's market cap?

    Nutriband has a market cap of $70.63M. Its enterprise value, which adds debt and subtracts cash, is $67.36M.

    How many shares of NTRB are outstanding?

    Nutriband has 12.16M shares outstanding. The count is up 8.36% from a year earlier.

    Does NTRB pay a dividend?

    No. Nutriband does not pay a dividend.

    How much debt does NTRB have?

    Nutriband has $153.54K of total debt and $3.42M of cash and equivalents, a net cash position of $3.27M.